M1 Kliniken AG Cash Flow Conversion Efficiency
M1 Kliniken AG cash flow conversion efficiency. Based on the latest financial reports, M1 Kliniken AG (M12) has a cash flow conversion efficiency ratio of 0.129x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€18.94 Million ≈ $22.14 Million USD) by net assets (€147.03 Million ≈ $171.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of M1 Kliniken AG (2013–2024)
Cash flow conversion efficiency of M1 Kliniken AG from 2013 to 2024. This chart illustrates how M1 Kliniken AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. View M12 share price today for real-time trading data and today's change.
M1 Kliniken AG Cash Flow Conversion Ratio Explained
M1 Kliniken AG cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
M1 Kliniken AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of M1 Kliniken AG ranked by their cash flow conversion efficiency. Also see M1 Kliniken AG stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Suzhou Fushilai Pharmaceutical Co. Ltd.
SHE:301258
|
N/A |
|
Panin Financial Tbk
JK:PNLF
|
0.014x |
|
SAB Biotherapeutics Inc
NASDAQ:SABS
|
-0.112x |
|
Isabella Bank Corporation
NASDAQ:ISBA
|
0.031x |
|
Hanwha Galleria Corp.
KO:452260
|
N/A |
|
Panama Petrochem Limited
NSE:PANAMAPET
|
0.041x |
|
Hunan Hengguang Technology Co.Ltd.
SHE:301118
|
0.049x |
|
MOZAYYX Acquisition Corp.
NYSE:MZYX
|
-0.001x |
Annual Cash Flow Conversion Efficiency for M1 Kliniken AG (2013–2024)
The table below shows the annual cash flow conversion efficiency of M1 Kliniken AG from 2013 to 2024. Review M1 Kliniken AG (M12) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €134.22 Million ≈ $156.92 Million |
€30.55 Million ≈ $35.71 Million |
0.228x | +317.38% |
| 2023-12-31 | €143.22 Million ≈ $167.44 Million |
€7.81 Million ≈ $9.13 Million |
0.055x | -62.44% |
| 2022-12-31 | €143.05 Million ≈ $167.24 Million |
€20.77 Million ≈ $24.28 Million |
0.145x | +29.50% |
| 2021-12-31 | €139.90 Million ≈ $163.56 Million |
€15.68 Million ≈ $18.34 Million |
0.112x | +35.51% |
| 2020-12-31 | €115.32 Million ≈ $134.82 Million |
€9.54 Million ≈ $11.15 Million |
0.083x | +205.11% |
| 2019-12-31 | €68.22 Million ≈ $79.76 Million |
€-5.37 Million ≈ $-6.28 Million |
-0.079x | -275.38% |
| 2018-12-31 | €63.74 Million ≈ $74.52 Million |
€2.86 Million ≈ $3.34 Million |
0.045x | +1.73% |
| 2017-12-31 | €47.28 Million ≈ $55.28 Million |
€2.09 Million ≈ $2.44 Million |
0.044x | -83.18% |
| 2016-12-31 | €30.26 Million ≈ $35.37 Million |
€7.94 Million ≈ $9.28 Million |
0.262x | +4642.01% |
| 2015-12-31 | €29.75 Million ≈ $34.78 Million |
€-171.80K ≈ $-200.85K |
-0.006x | -116.07% |
| 2014-12-31 | €25.39 Million ≈ $29.69 Million |
€912.58K ≈ $1.07 Million |
0.036x | +110.42% |
| 2013-12-31 | €15.12 Million ≈ $17.68 Million |
€-5.21 Million ≈ $-6.10 Million |
-0.345x | -- |
About M1 Kliniken AG
M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. It operates in two segments, Beauty and Trade. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; abdomino… Read more